EGFR Exon 20–Altered NSCLC: A Personalized Approach to Improve Patient Outcomes

Download All

Gain global insights on the emerging role of EGFR exon 20 insertion mutations in the management of advanced NSCLC with this comprehensive online program including expert-authored commentaries, a text module, and an on-demand webcast of a live CCO webinar with downloadable slidesets.

person default
Professor Keith M. Kerr, FRCPath
Joshua Sabari, MD

ClinicalThought

Get up to date on how and when to test for EGFR exon 20 insertion mutations in your patients with advanced NSCLC.

person default Professor Keith M. Kerr, FRCPath Released: August 5, 2021

Get expert insights on the use of 2 recently approved therapies for your patients with advanced NSCLC and EGFR exon 20 insertion mutations.

Joshua Sabari, MD Released: October 6, 2021
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Janssen Pharmaceutica NV

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue